ClearPoint Neuro, Inc. — Director's Dealing 2024

May 15, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2024-05-14

Reporting Person: Richards Timothy T. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-14	Common Stock	M	17153	—	Acquired	61561	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-14	Restricted Stock Units	$	M	17153	Disposed		Common Stock (17153)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders.